Literature DB >> 28504568

Lactobacillus rhamnosus CRL1505 nasal administration improves recovery of T-cell mediated immunity against pneumococcal infection in malnourished mice.

N Barbieri1,2, M Herrera1, S Salva1, J Villena1, S Alvarez1,3.   

Abstract

Immunobiotic lactic acid bacteria have become an interesting alternative for the prevention of respiratory infections. Previously, we demonstrated that the nasal administration of Lactobacillus rhamnosus CRL1505, during repletion of malnourished mice, resulted in diminished susceptibility to the challenge with the respiratory pathogen Streptococcus pneumoniae. Considering the known alterations induced by malnutrition on T lymphocytes and the importance of this cell population on the protection against respiratory pathogens, we aimed to study the effect of L. rhamnosus CRL1505 nasal administration on the recovery of T cell-mediated defences against pneumococcal infection in malnourished mice under nutritional recovery. Malnourished mice received a balanced conventional diet (BCD) for seven days or BCD for seven days with nasal L. rhamnosus CRL1505 supplementation during last two days of the treatment. After the treatments mice were infected with S. pneumoniae. Flow cytometry studies were carried out in bone marrow, thymus, spleen and lung to study T cells, and Th1/Th2 cytokine profiles were determined in broncho-alveolar lavages and serum. The administration of CRL1505 strain to malnourished mice under recovery reduced quantitative and qualitative alterations of CD4+ T cells in the bone marrow, thymus, spleen and lung induced by malnutrition. In addition, CRL1505 treatment augmented Th2-cytokines (interleukin 10 and 4) in respiratory and systemic compartments after pneumococcal infection. These results show that modulation of CD4+ T lymphocytes induced by L. rhamnosus CRL1505 has an important role in the beneficial effect induced by this strain on the recovery of malnourished mice. These data also indicate that nasally administered L. rhamnosus CRL1505 may represent a non-invasive alternative to modulate and improve the T cell-mediated immunity against respiratory pathogens in immunocompromised malnourished hosts.

Entities:  

Keywords:  Streptococcus pneumoniae; T lymphocytes; immunobiotics; immunocompromised hosts; lactic acid bacteria

Mesh:

Substances:

Year:  2017        PMID: 28504568     DOI: 10.3920/BM2016.0152

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  9 in total

1.  Antagonistic activity and mechanism of Lactobacillus rhamnosus SQ511 against Salmonella enteritidis.

Authors:  Shuiqin Shi; Li Gong; Hao Yu; Guangyu He; Jingjing Zhang; Yu Han; Yannan Liu; Jie Hu; Jinsheng Dong; Jia Liu; Kai Zhao; Duoqi Zhou
Journal:  3 Biotech       Date:  2022-05-11       Impact factor: 2.893

Review 2.  Commensal bacteria in the upper respiratory tract regulate susceptibility to infection.

Authors:  Sarah E Clark
Journal:  Curr Opin Immunol       Date:  2020-05-19       Impact factor: 7.486

3.  Are the immunomodulatory properties of Lactobacillus rhamnosus CRL1505 peptidoglycan common for all Lactobacilli during respiratory infection in malnourished mice?

Authors:  Yanina Kolling; Susana Salva; Julio Villena; Susana Alvarez
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 4.  Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.

Authors:  Ornella Spagnolello; Claudia Pinacchio; Letizia Santinelli; Paolo Vassalini; Giuseppe Pietro Innocenti; Gabriella De Girolamo; Silvia Fabris; Marta Giovanetti; Silvia Angeletti; Alessandro Russo; Claudio M Mastroianni; Massimo Ciccozzi; Giancarlo Ceccarelli; Gabriella d'Ettorre
Journal:  Chemotherapy       Date:  2021-03-23       Impact factor: 2.544

5.  Probiotic Combination CBLEB Alleviates Streptococcus pneumoniae Infection Through Immune Regulation in Immunocompromised Rats.

Authors:  Longxian Lv; Ling Peng; Li Shao; Ding Shi; Huiyong Jiang; Ren Yan
Journal:  J Inflamm Res       Date:  2022-02-15

Review 6.  The Open Challenge of in vitro Modeling Complex and Multi-Microbial Communities in Three-Dimensional Niches.

Authors:  Martina Oriano; Laura Zorzetto; Giuseppe Guagliano; Federico Bertoglio; Sebastião van Uden; Livia Visai; Paola Petrini
Journal:  Front Bioeng Biotechnol       Date:  2020-10-20

Review 7.  Role of probiotics to combat viral infections with emphasis on COVID-19.

Authors:  Aravind Sundararaman; Mousumi Ray; P V Ravindra; Prakash M Halami
Journal:  Appl Microbiol Biotechnol       Date:  2020-08-19       Impact factor: 4.813

8.  Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?

Authors:  Harry Cheuk-Hay Lau; Siew C Ng; Jun Yu
Journal:  Gastroenterology       Date:  2021-09-08       Impact factor: 22.682

Review 9.  Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?

Authors:  Giovanna Batoni; Giuseppantonio Maisetta; Esingül Kaya; Semih Esin
Journal:  Antibiotics (Basel)       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.